Immunity against cancer: lessons learned from melanoma

被引:157
作者
Houghton, AN
Gold, JS
Blachere, NE
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Sch, New York, NY 10021 USA
关键词
D O I
10.1016/S0952-7915(00)00195-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Most major advances in human cancer immunology and immunotherapy have come from studies in melanoma. We are beginning to understand the immune repertoire of T cells and antibodies that are active against melanoma, with recent glimpses of the CD4(+) T cell repertoire. The view of what the immune system can see is extending to mutations and parts of the genome that are normally invisible.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 59 条
  • [1] ALBINO AP, 1992, ONCOGENE, V7, P2315
  • [2] An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions
    Anichini, A
    Molla, A
    Mortarini, R
    Tragni, G
    Bersani, I
    Di Nicola, M
    Gianni, AM
    Pilotti, S
    Dunbar, R
    Cerundolo, V
    Parmiani, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (05) : 651 - 667
  • [3] Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma
    Bloom, MB
    PerryLalley, D
    Robbins, PF
    Li, Y
    ElGamil, M
    Rosenberg, SA
    Yang, JC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) : 453 - 459
  • [4] Coupling and uncoupling of tumor immunity and autoimmunity
    Bowne, WB
    Srinivasan, R
    Wolchok, JD
    Hawkins, WG
    Blachere, NE
    Dyall, R
    Lewis, JJ
    Houghton, AN
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (11) : 1717 - 1722
  • [5] Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymphocytes
    Chaux, P
    Vantomme, V
    Stroobant, V
    Thielemans, K
    Corthals, J
    Luiten, R
    Eggermont, AMM
    Boon, T
    van der Bruggen, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) : 767 - 777
  • [6] A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
    Chen, YT
    Scanlan, MJ
    Sahin, U
    Tureci, O
    Gure, AO
    Tsang, SL
    Williamson, B
    Stockert, E
    Pfreundschuh, M
    Old, LJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) : 1914 - 1918
  • [7] Chiari R, 2000, CANCER RES, V60, P4855
  • [8] Fc receptors are required in passive and active immunity to melanoma
    Clynes, R
    Takechi, Y
    Moroi, Y
    Houghton, A
    Ravetch, JV
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 652 - 656
  • [9] Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
    Clynes, RA
    Towers, TL
    Presta, LG
    Ravetch, JV
    [J]. NATURE MEDICINE, 2000, 6 (04) : 443 - 446
  • [10] Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: Implications for tumor immunotherapy
    Colella, TA
    Bullock, TNJ
    Russell, LB
    Mullins, DW
    Overwijk, WW
    Luckey, CJ
    Pierce, RA
    Restifo, NP
    Engelhard, VH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (07) : 1221 - 1231